1. Home
  2. LENZ vs TRIN Comparison

LENZ vs TRIN Comparison

Compare LENZ & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LENZ
  • TRIN
  • Stock Information
  • Founded
  • LENZ 2019
  • TRIN 2007
  • Country
  • LENZ United States
  • TRIN United States
  • Employees
  • LENZ N/A
  • TRIN N/A
  • Industry
  • LENZ Medicinal Chemicals and Botanical Products
  • TRIN Finance/Investors Services
  • Sector
  • LENZ Health Care
  • TRIN Finance
  • Exchange
  • LENZ Nasdaq
  • TRIN Nasdaq
  • Market Cap
  • LENZ 886.2M
  • TRIN 786.4M
  • IPO Year
  • LENZ 2021
  • TRIN 2021
  • Fundamental
  • Price
  • LENZ $34.32
  • TRIN $14.26
  • Analyst Decision
  • LENZ Strong Buy
  • TRIN Strong Buy
  • Analyst Count
  • LENZ 6
  • TRIN 3
  • Target Price
  • LENZ $35.40
  • TRIN $15.17
  • AVG Volume (30 Days)
  • LENZ 157.8K
  • TRIN 508.5K
  • Earning Date
  • LENZ 11-06-2024
  • TRIN 10-30-2024
  • Dividend Yield
  • LENZ N/A
  • TRIN 14.28%
  • EPS Growth
  • LENZ N/A
  • TRIN 12.74
  • EPS
  • LENZ N/A
  • TRIN 1.72
  • Revenue
  • LENZ N/A
  • TRIN $205,164,000.00
  • Revenue This Year
  • LENZ N/A
  • TRIN $35.34
  • Revenue Next Year
  • LENZ N/A
  • TRIN $17.55
  • P/E Ratio
  • LENZ N/A
  • TRIN $8.28
  • Revenue Growth
  • LENZ N/A
  • TRIN 20.08
  • 52 Week Low
  • LENZ $2.12
  • TRIN $13.05
  • 52 Week High
  • LENZ $38.93
  • TRIN $15.44
  • Technical
  • Relative Strength Index (RSI)
  • LENZ 62.24
  • TRIN 58.75
  • Support Level
  • LENZ $31.59
  • TRIN $14.04
  • Resistance Level
  • LENZ $35.40
  • TRIN $14.37
  • Average True Range (ATR)
  • LENZ 2.74
  • TRIN 0.21
  • MACD
  • LENZ -0.08
  • TRIN 0.06
  • Stochastic Oscillator
  • LENZ 60.16
  • TRIN 92.05

About LENZ LENZ Therapeutics Inc. Common Stock

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

About TRIN Trinity Capital Inc.

Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.

Share on Social Networks: